TASK-1 and TASK-3 may form heterodimers in human atrial cardiomyocytes
- PMID: 25655935
- DOI: 10.1016/j.yjmcc.2015.01.017
TASK-1 and TASK-3 may form heterodimers in human atrial cardiomyocytes
Abstract
TASK-1 channels have emerged as promising drug targets against atrial fibrillation, the most common arrhythmia in the elderly. While TASK-3, the closest relative of TASK-1, was previously not described in cardiac tissue, we found a very prominent expression of TASK-3 in right human auricles. Immunocytochemistry experiments of human right auricular cardiomyocytes showed that TASK-3 is primarily localized at the plasma membrane. Single-channel recordings of right human auricles in the cell-attached mode, using divalent-cation-free solutions, revealed a TASK-1-like channel with a single-channel conductance of about 30pS. While homomeric TASK-3 channels were not found, we observed an intermediate single-channel conductance of about 55pS, possibly reflecting the heteromeric channel formed by TASK-1 and TASK-3. Subsequent experiments with TASK-1/TASK-3 tandem channels or with co-expressed TASK-1 and TASK-3 channels in HEK293 cells or Xenopus oocytes, supported that the 55pS channels observed in right auricles have electrophysiological characteristics of TASK-1/TASK-3 heteromers. In addition, co-expression experiments and single-channel recordings suggest that heteromeric TASK-1/TASK-3 channels have a predominant surface expression and a reduced affinity for TASK-1 blockers. In summary, the evidence for heteromeric TASK-1/TASK-3 channel complexes together with an altered pharmacologic response to TASK-1 blockers in vitro is likely to have further impact for studies isolating ITASK-1 from cardiomyocytes and for the development of drugs specifically targeting TASK-1 in atrial fibrillation treatment.
Keywords: Atrial fibrillation; Cardiomyocytes; Heteromers; K(2P) channel; Right human auricles; TASK.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Similar articles
-
Pharmacologic TWIK-Related Acid-Sensitive K+ Channel (TASK-1) Potassium Channel Inhibitor A293 Facilitates Acute Cardioversion of Paroxysmal Atrial Fibrillation in a Porcine Large Animal Model.J Am Heart Assoc. 2020 May 18;9(10):e015751. doi: 10.1161/JAHA.119.015751. Epub 2020 May 9. J Am Heart Assoc. 2020. PMID: 32390491 Free PMC article.
-
TASK-1 channels may modulate action potential duration of human atrial cardiomyocytes.Cell Physiol Biochem. 2011;28(4):613-24. doi: 10.1159/000335757. Epub 2011 Dec 14. Cell Physiol Biochem. 2011. PMID: 22178873 Free PMC article.
-
Atrial fibrillation and heart failure-associated remodeling of two-pore-domain potassium (K2P) channels in murine disease models: focus on TASK-1.Basic Res Cardiol. 2018 Jun 7;113(4):27. doi: 10.1007/s00395-018-0687-9. Basic Res Cardiol. 2018. PMID: 29881975
-
Inhibition of cardiac two-pore-domain K+ (K2P) channels--an emerging antiarrhythmic concept.Eur J Pharmacol. 2014 Sep 5;738:250-5. doi: 10.1016/j.ejphar.2014.05.056. Epub 2014 Jun 10. Eur J Pharmacol. 2014. PMID: 24927994 Review.
-
Atrial-selective K+ channel blockers: potential antiarrhythmic drugs in atrial fibrillation?Can J Physiol Pharmacol. 2017 Nov;95(11):1313-1318. doi: 10.1139/cjpp-2017-0024. Epub 2017 Jul 24. Can J Physiol Pharmacol. 2017. PMID: 28738160 Review.
Cited by
-
Characterization and regulation of wild-type and mutant TASK-1 two pore domain potassium channels indicated in pulmonary arterial hypertension.J Physiol. 2019 Feb;597(4):1087-1101. doi: 10.1113/JP277275. Epub 2018 Nov 24. J Physiol. 2019. PMID: 30365877 Free PMC article.
-
The Experimental TASK-1 Potassium Channel Inhibitor A293 Can Be Employed for Rhythm Control of Persistent Atrial Fibrillation in a Translational Large Animal Model.Front Physiol. 2021 Jan 21;11:629421. doi: 10.3389/fphys.2020.629421. eCollection 2020. Front Physiol. 2021. PMID: 33551849 Free PMC article.
-
Research progress of two-pore potassium channel in myocardial ischemia-reperfusion injury.Front Physiol. 2024 Oct 29;15:1473501. doi: 10.3389/fphys.2024.1473501. eCollection 2024. Front Physiol. 2024. PMID: 39534859 Free PMC article. Review.
-
Advances in the Understanding of Two-Pore Domain TASK Potassium Channels and Their Potential as Therapeutic Targets.Molecules. 2022 Nov 28;27(23):8296. doi: 10.3390/molecules27238296. Molecules. 2022. PMID: 36500386 Free PMC article. Review.
-
TASK-1 and TASK-3 channels modulate pressure overload-induced cardiac remodeling and dysfunction.Am J Physiol Heart Circ Physiol. 2020 Mar 1;318(3):H566-H580. doi: 10.1152/ajpheart.00739.2018. Epub 2020 Jan 24. Am J Physiol Heart Circ Physiol. 2020. PMID: 31977249 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
